Latest News

CVS Earnings Topped Expectations. Its Stock Is Dropping.

Text size

CVS stock is falling after earnings.
Bryan Bedder/Getty Images for CVS Pharmacy

  CVS Health stock was falling after reporting better-than-expected earnings Wednesday but confirming full-year guidance that appeared to disappoint.

The company reported revenue of $76.6 billion for the fourth-quarter ending in December, up 10.1% compared with the prior year, beating the FactSet consensus of $75.6 billion. Adjusted earnings per share were $1.98, which topped the FactSet consensus of $1.83.

Same-store sales in the pharmacy segment were up 8.8% from last year and same-store retail sales rose 12.3%. Both were bolstered by the company’s administration of 11 million Covid-19 vaccinations and 8 million tests over the three-month period. 

CVS also confirmed its full-year adjusted EPS guidance range of $8.10 to $8.30. The analyst consensus was for a profit of $8.28. Revenue guidance was also confirmed for $304 billion to $309 billion.

Shares of CVS were down 2.4% in premarket trading to $108.14.

This is a developing story. Check back for updates.

Write to Logan Moore at

Key Supplier of Wafers for Chips Says It’s Sold Out Through 2026

Previous article

Disney’s Earnings Are Today. Parks and Streaming Are Key.

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News